Select Medical (SEM) Upgraded to Buy by ValuEngine

Select Medical (NYSE:SEM) was upgraded by equities research analysts at ValuEngine from a “hold” rating to a “buy” rating in a report released on Friday.

Several other brokerages have also commented on SEM. Zacks Investment Research lowered Select Medical from a “hold” rating to a “sell” rating in a report on Friday, October 27th. Robert W. Baird set a $25.00 price objective on Select Medical and gave the company a “buy” rating in a report on Monday, October 23rd. Royal Bank of Canada reissued a “buy” rating and issued a $19.00 price objective on shares of Select Medical in a report on Friday, October 13th. Deutsche Bank reissued a “buy” rating and issued a $22.00 price objective on shares of Select Medical in a report on Monday, November 6th. Finally, Bank of America raised Select Medical from an “underperform” rating to a “neutral” rating and set a $19.00 price objective on the stock in a report on Thursday, January 4th. Two analysts have rated the stock with a sell rating, two have issued a hold rating and six have issued a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $20.25.

Shares of Select Medical (NYSE:SEM) traded down $0.65 during mid-day trading on Friday, reaching $17.45. The company had a trading volume of 373,396 shares, compared to its average volume of 734,489. The company has a debt-to-equity ratio of 3.36, a quick ratio of 1.51 and a current ratio of 1.51. The stock has a market capitalization of $2,340.00, a PE ratio of 24.24, a P/E/G ratio of 1.10 and a beta of 1.30. Select Medical has a 52 week low of $12.00 and a 52 week high of $19.77.

Select Medical (NYSE:SEM) last issued its quarterly earnings data on Thursday, November 2nd. The health services provider reported $0.14 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.02). Select Medical had a net margin of 2.21% and a return on equity of 11.44%. The business had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same period in the previous year, the business posted $0.06 earnings per share. The firm’s revenue for the quarter was up 4.1% on a year-over-year basis. research analysts anticipate that Select Medical will post 0.86 EPS for the current year.

In other news, insider Martin F. Jackson sold 156,603 shares of Select Medical stock in a transaction that occurred on Wednesday, December 13th. The stock was sold at an average price of $17.06, for a total value of $2,671,647.18. Following the sale, the insider now directly owns 1,790,601 shares of the company’s stock, valued at $30,547,653.06. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Scott A. Romberger sold 5,000 shares of Select Medical stock in a transaction that occurred on Wednesday, November 29th. The stock was sold at an average price of $17.97, for a total value of $89,850.00. Following the completion of the sale, the insider now directly owns 168,211 shares in the company, valued at $3,022,751.67. The disclosure for this sale can be found here. Insiders sold 295,955 shares of company stock worth $5,052,199 over the last ninety days. Corporate insiders own 19.93% of the company’s stock.

Large investors have recently modified their holdings of the company. Vanguard Group Inc. boosted its stake in Select Medical by 3.9% during the second quarter. Vanguard Group Inc. now owns 9,929,821 shares of the health services provider’s stock worth $152,423,000 after buying an additional 369,044 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Select Medical by 1.8% during the third quarter. Dimensional Fund Advisors LP now owns 8,289,370 shares of the health services provider’s stock worth $159,154,000 after buying an additional 146,892 shares during the last quarter. Orbimed Advisors LLC boosted its stake in Select Medical by 51.3% during the third quarter. Orbimed Advisors LLC now owns 5,578,500 shares of the health services provider’s stock worth $107,107,000 after buying an additional 1,891,100 shares during the last quarter. Northern Trust Corp boosted its stake in Select Medical by 14.6% during the second quarter. Northern Trust Corp now owns 2,325,289 shares of the health services provider’s stock worth $35,694,000 after buying an additional 296,087 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its stake in Select Medical by 2.3% during the fourth quarter. Victory Capital Management Inc. now owns 1,252,350 shares of the health services provider’s stock worth $22,104,000 after buying an additional 27,997 shares during the last quarter. 77.89% of the stock is currently owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: This piece was published by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of US & international copyright and trademark legislation. The correct version of this piece can be read at https://www.americanbankingnews.com/2018/02/04/select-medical-sem-upgraded-to-buy-by-valuengine.html.

Select Medical Company Profile

Select Medical Holdings Corporation is an operator of specialty hospitals, outpatient rehabilitation clinics and occupational medicine centers in the United States. The Company’s segments include specialty hospitals, outpatient rehabilitation, Concentra and Other. The specialty hospitals segment consists of hospitals designed to serve the needs of long term acute patients and hospitals designed to serve patients that require intensive medical rehabilitation care.

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply